PMA device
Everflex Self-Expanding Peripheral Stent System (Everflex)
Medtronic Vascular, Inc. · Stent, Superficial Femoral Artery (NIP, Class III) · First FDA decision Mar 7, 2012, newest Aug 5, 2025Peripheral artery disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
PMA pathway
Device trials
6
Naming "Everflex Self-Expanding"
MAUDE reports
1,135
Brand "Everflex Self-Expanding", since 2015
PubMed studies
0
Mentioning "Everflex Self-Expanding"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Everflex Self-Expanding Peripheral Stent System (Everflex)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
P110023-S056 · Decided Aug 5, 2025 · 187 days after receipt · Normal 180 Day Track
Device type: STENT, SUPERFICIAL FEMORAL ARTERY (NIP) · Cardiology
5 more FDA decisions with a free account
Older decisions: P110023-S006, P110023
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R8Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R7Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R6Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R3Updated Sep 21, 2026
- Carotid Artery Stenting in Post-Approval StudiesNational analysisReview closedCAG-00259NUpdated Sep 17, 2026
- Carotid Artery StentingNational analysisReview closedCAG-00085RUpdated Sep 17, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Everflex Self-Expanding", any status and sponsor, newest update first.
- A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery DiseasePivotal-lookingCompleted
Kantonsspital Winterthur KSWAcademic, hospital or other
NCT03941314 · 300 participants · Start Jun 25, 2019 · Primary completion Mar 19, 2026
Device: Supera® Peripheral Stent System; EverFlex™ Self-Expanding Peripheral Stent System · For: Peripheral Arterial Disease
Sites: Málaga, Spain; Sankt Gallen, Switzerland; Winterthur, Switzerland
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Everflex Self-Expanding", and for the whole product code for context.
This brand
1,135 reports: 610 malfunction, 495 injury, 30 death
Whole product code NIP
9,363 reports: 4,911 malfunction, 4,303 injury, 147 death
Newest reports for this brand
2183870-2026-00540 · Received Oct 29, 2026 · Event dated Sep 30, 2026
Device type: Stent, Superficial Femoral Artery (NIP)
Device problem as coded: Activation, Positioning or Separation Problem; Difficult to Advance
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Protege GPS Self-Expanding Peripheral Stent System, product number SERB65-09-60-80, Sterile.Completed
Z-0623-2024 · Started Nov 20, 2023 · Posted by FDA Jan 2, 2024
Reason given: Seal defects could compromise the ability of the product packaging to maintain sterility.
Cause as FDA categorized it: Packaging change control · Device type: Stent, Superficial Femoral Artery (NIP)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Everflex Self-Expanding"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NIP.
- GORE VIABAHN EndoprosthesisW. L. Gore & Associates, Inc. · PMA 2022
- Supera Peripheral Stent SystemAbbott Vascular (Idef Technologies Inc) · PMA 2025
- LifeStent Vascular Stent SystemBard Peripheral Vascular, Inc. · PMA 2023
- Innova Vascular Self-Expanding Stent SystemBoston Scientific Corporation · PMA 2021
- BioMimics 3D Vascular Stent SystemVeryan Medical, Ltd. · PMA 2025
- Bard Lifestent Vascular Stent SystemBard Peripheral Vascular, Inc. · PMA 2016
- Astron Pulsar and Pulsar-18 Stent SystemsBiotronik AG · PMA 2018
- Misago Peripheral Self-Expanding Stent SystemTerumo Medical Corporation · PMA 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.